Fludarabine, Cytarabine, Idarubicin and Etoposide (FLAIE) schedule is safe and active for young patients with newly diagnosed acute myeloid leukemia (AML): Results of a multicentric phase III Italian study

被引：0
|
作者：
Abbenante, Mariachiara [1 ]
Papayannidis, Cristina [1 ]
Iacobucci, Ilaria [1 ]
Candoni, Anna [2 ]
Paolini, Stefania [1 ]
Malagola, Michele [3 ]
Emanuela, Ottaviani [1 ]
Lonetti, Annalisa [1 ]
Curti, Antonio [1 ]
Parisi, Sarah [1 ]
Testoni, Nicoletta [1 ]
Lama, Barbara [1 ]
Baccarani, Michele [1 ]
Martinelli, Giovanni [1 ]
机构：
[1] Univ Bologna, Dept Hematol Oncol Seragnoli, Bologna, Italy
[2] Div Hematol & BMT, Udine, Italy
[3] Univ Brescia, Hematol & BMT Unit, Brescia, Italy
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.4M2011-2236
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2236
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A Randomized Phase 2 Study of Idarubicin and Cytarabine With Clofarabine or Fludarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia
    Jabbour, Elias
    Short, Nicholas J.
    Ravandi, Farhad
    Huang, Xuelin
    Xiao, Lianchun
    Garcia-Manero, Guillermo
    Plunkett, William
    Gandhi, Varsha
    Sasaki, Koji
    Pemmaraju, Naveen
    Daver, Naval G.
    Borthakur, Gautam
    Jain, Nitin
    Konopleva, Marina
    Estrov, Zeev
    Kadia, Tapan M.
    Wierda, William G.
    DiNardo, Courtney D.
    Brandt, Mark
    O'Brien, Susan M.
    Cortes, Jorge E.
    Kantarjian, Hagop
    CANCER, 2017, 123 (22) : 4430 - 4439
  • [2] FLAIE (FLUDARABINE, CYTARABINE, IDARUBICIN AND ETOPOSIDE) AS INDUCTION CHEMOTHERAPY OF ADULT ACUTE MYELOID LEUKEMIA. A PILOT STUDY REPORT
    Candoni, A.
    Simeone, E.
    Michelutti, A.
    Damiani, D.
    Russo, D.
    Fanin, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 123 - 123
  • [3] Interim results of a phase I/II randomized study of clofarabine, idarubicin, and cytarabine (CIA) versus fludarabine, idarubicin, and cytarabine (FIA) for newly diagnosed or relapsed patients (pts) with acute myeloid leukemia (AML).
    Mathisen, Michael
    Kantarjian, Hagop
    Faderl, Stefan
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kadia, Tapan M.
    Daver, Naval Guastad
    O'Brien, Susan Mary
    Dorkhom, Stephan Joseph
    Pierce, Sherry
    Lira, Cynthia
    Cortes, Jorge E.
    Jabbour, Elias
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Updated Results of a Randomized Phase II Trial of Idarubicin and Cytarabine with Clofarabine or Fludarabine in Patients with Newly Diagnosed Acute Myeloid Leukemia
    Short, Nicholas J.
    Ravandi, Farhad
    Huang, Xuelin
    Cortes, Jorge E.
    Pemmaraju, Naveen
    Daver, Naval
    Khouri, Rita B.
    Borthakur, Gautam
    Jain, Nitin
    Konopleva, Marina
    Estrov, Zeev
    Garcia-Manero, Guillermo
    Kadia, Tapan M.
    Wierda, William G.
    DiNardo, Courtney D.
    O'Brien, Susan M.
    Shah, Syed
    Pike, Allison
    Brandt, Mark
    Kantarjian, Hagop M.
    Jabbour, Elias J.
    BLOOD, 2016, 128 (22)
  • [5] Idarubicin and cytarabine with clofarabine or fludarabine in adults with newly diagnosed acute myeloid leukemia: Updated results of a randomized phase II study.
    Issa, Ghayas C.
    Kantarjian, Hagop M.
    Short, Nicholas James
    Ravandi, Farhad
    Huang, Xuelin
    Garcia-Manero, Guillermo
    Plunkett, William
    Gandhi, Varsha
    Pemmaraju, Naveen
    Daver, Naval Guastad
    Borthakur, Gautam
    Jain, Nitin
    Konopleva, Marina
    Estrov, Zeev
    Kadia, Tapan M.
    Dinardo, Courtney Denton
    Brandt, Mark
    O'Brien, Susan Mary
    Cortes, Jorge E.
    Jabbour, Elias
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] A RANDOMIZED PHASE II STUDY OF IDARUBICIN AND CYTARABINE WITH EITHER CLOFARABINE OR FLUDARABINE IN ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
    Short, N.
    Kantarjian, H.
    Ravandi, F.
    Huang, X.
    Xiao, L.
    Garcia-Manero, G.
    Plunkett, W.
    Gandhi, V.
    Sasaki, K.
    Pemmaraju, N.
    Daver, N.
    Borthakur, G.
    Jain, N.
    Konopleva, M.
    Estrov, Z.
    Kadia, T.
    Wierda, W.
    DiNardo, C.
    Brandt, M.
    O'Brien, S.
    Cortes, J.
    Jabbour, E.
    HAEMATOLOGICA, 2017, 102 : 53 - 53
  • [7] FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience
    Candoni, Anna
    Simeone, Erica
    Tiribelli, Mario
    Malagola, Michele
    Russo, Domenico
    Fanin, Renato
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (10) : 690 - 692
  • [8] Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin
    McHayleh, Wassim
    Sehgal, Rajesh
    Redner, Robert L.
    Raptis, Anastasios
    Agha, Mounzer
    Natale, James
    Luong, The Minh
    Schlesselman, James J.
    Foon, Kennteh A.
    Boyiadzis, Michael
    LEUKEMIA & LYMPHOMA, 2009, 50 (11) : 1848 - 1853
  • [9] Updated Results of a Phase I/II, Randomized Study of Clofarabine Combined with Idarubicin and Cytarabine (CIA) or Fludarabine Combined with Idarubicin and Cytarabine (FIA) for the Treatment of Patients (pts) with Newly Diagnosed or Relapsed/Refractory (RR) Acute Myeloid Leukemia (AML)
    Mathisen, Michael S.
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Pemmaraju, Naveen
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    O'Brien, Susan
    Quintas-Cardama, Alfonso
    Ghanem, Hady
    Daver, Naval G.
    Pierce, Sherry A.
    Lira, Cynthia
    Faderl, Stefan
    Jabbour, Elias
    BLOOD, 2012, 120 (21)
  • [10] Four-drugs induction intensified regimens (idarubicin, cytarabine and etoposide plus fludarabine or mylotarg FLAIE and MyAIE) for acute myeloid leukemia. Results of a pilot study
    Paolini, S.
    Piccaluga, P. P.
    Rondoni, M.
    Malagola, M.
    Papayannidis, C.
    Laterza, C.
    Verlicchi, L.
    De Rosa, F.
    Ottaviani, E.
    Iacobucci, I.
    Russo, D.
    Candoni, A.
    Fanin, R.
    Visani, G.
    Baccarani, M.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 72 - 72
12345